BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong H, Liu S, Cao F, Zhao Y, Zhou J, Tang F, Peng Z, Li Y, Xu S, Wang C, Yang G, Li ZQ. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine. Front Immunol 2021;12:709986. [PMID: 34512630 DOI: 10.3389/fimmu.2021.709986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Jiang N, Chen M, Sui B, Liu X. Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1064754] [Reference Citation Analysis]
2 Yu Y, Huang Y, Li C, Ou S, Xu C, Kang Z. Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1047004] [Reference Citation Analysis]
3 Yu X, Che Y, Li W, Zhang P, Yu Y, Chen J, Gong T, Cao F. DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1055567] [Reference Citation Analysis]
4 Wang ZL, Huang RY, Han B, Wu F, Sun ZY, Li GZ, Zhang W, Zhao Z, Liu X. Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development. Chin Neurosurg J 2022;8:34. [PMID: 36307882 DOI: 10.1186/s41016-022-00301-4] [Reference Citation Analysis]
5 Xiong R, Wang H, Li Y, Zheng J, Cheng Y, Liu S, Yang G. Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. Front Genet 2022;13:1005271. [DOI: 10.3389/fgene.2022.1005271] [Reference Citation Analysis]
6 Prieto-fernández L, Menéndez ST, Otero-rosales M, Montoro-jiménez I, Hermida-prado F, García-pedrero JM, Álvarez-teijeiro S. Pathobiological functions and clinical implications of annexin dysregulation in human cancers. Front Cell Dev Biol 2022;10:1009908. [DOI: 10.3389/fcell.2022.1009908] [Reference Citation Analysis]
7 Lu T, Xu R, Wang C, Zhao J, Peng B, Wang J, Zhang L. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Front Genet 2022;13:853113. [DOI: 10.3389/fgene.2022.853113] [Reference Citation Analysis]
8 Chen J, Shen S, Li Y, Fan J, Xiong S, Xu J, Zhu C, Lin L, Dong X, Duan W, Zhao Y, Qian X, Liu Z, Wei Y, Christiani DC, Zhang R, Chen F. APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance. eBioMedicine 2022;79:104007. [DOI: 10.1016/j.ebiom.2022.104007] [Reference Citation Analysis]
9 Chen Z, Wang X, Yan Z, Zhang M. Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development. Cancer Med 2022. [PMID: 35285582 DOI: 10.1002/cam4.4633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu R, Lu T, Zhao J, Wang J, Peng B, Zhang L. Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development. Front Cell Dev Biol 2022;10:815596. [PMID: 35265614 DOI: 10.3389/fcell.2022.815596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]